“Marc Beer Renovia fight against pelvic disorders “

Apart from being the CEO, Marc Beer is also the chairman and co-founder of Renovia Inc. Marc Beer is an experienced manager having twenty-five years specializing in commercialization and development in both pharmaceutical, diagnostic and device industries.


Marc Beer was the former Avegerion pharmaceuticals CEO. After leaving Aegerion where he had worked for five years, Renovia Inc. was his first venture. Marc Beer stated that he thought of the company after meeting Dr. Ray Iglesias. Dr. Ray is a gynecologist who had done pelvic floor surgeries for the last thirty years.


He had spent the last seven to ten years discovering how he could help women with pelvic disorders without using surgery. It was then that Marc Beer decided he had found the right person to think about innovation to develop products to keep women with pelvic disorders from going through unnecessary surgeries.


Renovia Inc. was formed to create new products for pelvic floor disorders. According to researchers, pelvic disorders affect nearly two fifty million worldwide. Marc beer renovia is a medtech company that is focused on creating and developing different diagnostic as well as therapeutic products to heal pelvic floor disorders. Urinary incontinence is an example of and a common pelvic floor disorder.


The first product that Marc Beer Renovia created to battle with pelvic disorders was Leva which received FDA approval back in April 2018. Leva has gone on to attract funding for its further development. Longwood fund which is an investment firm that is focused on health care investments had invested in Leva’s early production and trials.


The firm has decided to further invest in the series b round. The series B round will be headed by perspective advisors from New York and Ascension Ventures who are based in Missouri. The funding that Marc Beer Renovia will receive will be used to develop and test four more rounds of therapeutic and diagnostic products which will include a new generation of leva. The series B managed to get $32 million and $10 million regarding venture debt.


Mr. Marc Beer said that he was very excited to have the support of leading health care investors who share the same goal and vision as him of having better diagnosis and treatment methods so that they can improve the lives of women affected by pelvic disorders.


He added that he was confident that by combining his’ firms innovative and sensor technology and forming a digital health platform they would be able to give customers important information regarding new treatment options. By doing this, they will also improve the understanding and knowledge that people have on pelvic disorders and lower health care costs. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer


Renovia Is A Medtech Startup By Marc Beer That Is Soaring To The Top

Marc Beer has been in the pharmaceutical industry for more than two decades now, working to improve health care for everyone, especially women lately with Renovia. Renovia is a medtech startup that is specifically focused on finding treatments for women at the moment for pelvic floor disorders since more than 200 million women from around the world are suffering from this disease. That being said, Renovia is dedicated to research and there is much more to come in the treatment department once the research is completed. Marc Beer has developed other treatments in the past to help people with their illnesses, such as high cholesterol, but the FDA gave him trouble while he was trying to get it out to the public, questing his motives. This is what inspired Marc to start up Renovia, a medtech company dedicated to helping people and developing treatments. After a couple years of research, Renovia developed the product Leva, which has already gone on to be approved by the FDA and is ready to enter the market for millions of women.


Marc Beer co-founded Renovia with two other people passionate about healthcare, Ramon Iglesias and Yolanda Lorie. Together, Renovia is quickly rising to the top and becoming and well-known company throughout the region. Women from all over are extremely supportive of Renovia’s research, as they are specifically dedicated to researching diseases affecting women. So far, Renovia has done extremely well with their funding rounds, pulling in more than 42 million dollars in their last funding round alone thanks to many support organizations and individuals that want to see new treatments enter the market. There is still a lot of work to do and research to do for Renovia and their scientists to improve Leva and create new treatments as well. According to Marc Beer, Leva could be improved with more funding to make it more sophisticated and even portable, but that may take a couple more years. There is much more to come from Renovia and with Marc Beer leading the team, they are sure to help millions of people around the world with their treatments. Learn more: https://www.linkedin.com/in/marcbeer